ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,169Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 973

$416K Total Retail Price of All Prescriptions

Rank: 220 out of 973

437 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,079 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
HYDROCODONE-ACETAMINOPHEN 580 480 S3 1 4
FUROSEMIDE 356 345 2 6
WARFARIN SODIUM 338 317 3 10
LISINOPRIL 321 294 4 3
SIMVASTATIN 313 300 5 1
LEVOTHYROXINE SODIUM 311 307 6 2
AMLODIPINE BESYLATE 286 281 7 7
OMEPRAZOLE 245 231 8 5
PANTOPRAZOLE SODIUM 227 195 9 37
METOPROLOL TARTRATE 222 212 10 13
METFORMIN HCL 219 187 11 8
ATENOLOL 208 179 12 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 175 159 13 25
DIGOXIN 166 166 14 32
HYDROCHLOROTHIAZIDE 158 148 15 11
POTASSIUM CHLORIDE 152 141 16 9
GABAPENTIN 147 111 17 12
ATORVASTATIN CALCIUM 116 112 18 15
CITALOPRAM HBR 105 105 19 14
ZOLPIDEM TARTRATE 102 93 20 20
DONEPEZIL HCL 93 93 21 26
LOSARTAN POTASSIUM 91 91 22 19
METOPROLOL SUCCINATE 89 89 23 17
TAMSULOSIN HCL 89 86 23 28
FENTANYL 87 77 S2 25 53
AMITRIPTYLINE HCL 84 74 R 26 52
ALLOPURINOL 78 71 27 29
SYNTHROID 77 77 28 50
FLUOXETINE HCL 76 76 29 56
LOVASTATIN 76 76 29 38
CEPHALEXIN 75 66 31 75
CARVEDILOL 70 70 32 27
TRIAMTERENE-HYDROCHLOROTHIAZID 69 66 33 140
GLIPIZIDE 68 62 34 69
NAMENDA 68 57 34 31
DOXAZOSIN MESYLATE 67 67 36 87
ENALAPRIL MALEATE 65 65 37 55
METFORMIN HCL ER 65 52 37 58
POLYETHYLENE GLYCOL 3350 65 52 37 36
ISOSORBIDE MONONITRATE ER 61 61 40 85
BENAZEPRIL HCL 59 59 41 62
GLIMEPIRIDE 59 59 41 41
PREDNISONE 56 50 43 33
TRIAMTERENE-HCTZ 56 56 43 51
MORPHINE SULFATE ER 55 38 S2 45 74
MELOXICAM 55 48 45 23
VESICARE 53 52 47 133
ALENDRONATE SODIUM 53 49 47 24
OXYCODONE-ACETAMINOPHEN 51 43 S2 49 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.